ORPH Stock: What to Know as Orphazyme Pops Again Ahead of June 17 Catalyst

investorplace2021-06-17

The meme stock crowd have their sights set on new targets and orphan drug treatment company Orphazyme(NASDAQ:ORPH) is up nearly 90% today as a result. ORPH stock has been trading jaggedly since last ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

eyescold
2021-06-20
eyescold
?
WilliamWCW
2021-06-18
WilliamWCW
?
Marco0os
2021-06-17
Marco0os
Time to buy in
Guat65
2021-06-17
Guat65
Haj
- Xav:
  HaJ
PanaCota
2021-06-17
PanaCota
Like n comment pls
Liangwayne
2021-06-17
Liangwayne
What’s with the recent hype on ORPH?

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1103057922?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-06-17 15:48","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1103057922","market":"us","top_or_hot":-1,"title":"ORPH Stock: What to Know as Orphazyme Pops Again Ahead of June 17 Catalyst","media":"investorplace","content":"<div>\n<p>The meme stock crowd have their sights set on new targets and orphan drug treatment company Orphazyme(NASDAQ:ORPH) is up nearly 90% today as a result. ORPH stock has been trading jaggedly since last ...</p>\n\n<a href=\"https://investorplace.com/2021/06/orph-stock-what-to-know-as-orphazyme-pops-again-ahead-of-june-17-catalyst/\">Source Link</a>\n\n</div>\n","source":"lsy1606302653667","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ORPH Stock: What to Know as Orphazyme Pops Again Ahead of June 17 Catalyst</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nORPH Stock: What to Know as Orphazyme Pops Again Ahead of June 17 Catalyst\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-17 15:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/06/orph-stock-what-to-know-as-orphazyme-pops-again-ahead-of-june-17-catalyst/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The meme stock crowd have their sights set on new targets and orphan drug treatment company Orphazyme(NASDAQ:ORPH) is up nearly 90% today as a result. ORPH stock has been trading jaggedly since last ...</p>\n\n<a href=\"https://investorplace.com/2021/06/orph-stock-what-to-know-as-orphazyme-pops-again-ahead-of-june-17-catalyst/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://investorplace.com/2021/06/orph-stock-what-to-know-as-orphazyme-pops-again-ahead-of-june-17-catalyst/","article_id":"1103057922","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1103057922","pubTimestamp":1623916087,"sourceInfo":{"source_id":"lsy1606302653667","name":"InvestorPlace"},"weMediaInfo":null,"summary":"The meme stock crowd have their sights set on new targets and orphan drug treatment company Orphazym","collect":0,"end_time":0,"defaultTopTitle":"investorplace.com","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"ORPH股票：在6月17日催化剂之前，Orphazyme再次流行","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ORPH":0.9},"content_text":"The meme stock crowd have their sights set on new targets and orphan drug treatment company Orphazyme(NASDAQ:ORPH) is up nearly 90% today as a result. ORPH stock has been trading jaggedly since last week,at one point up more than 1,000% on Friday, June 11.\nTrading volume of 115 million shares on the day at time of writing was dramatically up from an average daily trading volume of 1.3 million. Orphazyme management released a press release on Friday saying there wasno reason for the stock movement.\nThe U.S. Food and Drug Administration has set areview date of June 17 for ORPH stock’s key drug candidate ariclomal, which will be used to treat Niemann-Pick Disease Type C.\nThe company is also exploring the efficacy of ariclomal in treating other orphan diseases, though that endeavor hasn’t yielded positive results yet. Two different Phase 2/3 trials for treatment ofInclusion Body MyositisandAmyotrophic Lateral Sclerosisdid not meet their primary and secondary endpoints. In the company’s 2020 annual report, released in March 2021,addressable markets for IBM and ALS made up 45,000 of 62,000 patientsacross the four diseases discussed.\nORPH stock is presently covered by two analysts, with aprice consensus of $16. That’s more than 15% lower than its current price of $18.88.Meme stock traders have announced their intentionto send Orphazyme to the moon, but it’s hard to believe the stock won’t deflate following FDA results, even if positive.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":164378054,"gmtCreate":1624175647078,"gmtModify":1703830193146,"author":{"id":"3582062230385855","authorId":"3582062230385855","authorIdStr":"3582062230385855","name":"eyescold","avatar":"https://static.tigerbbs.com/947cfb8056822e3c4b4c3ace4c59dd6f","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3582062230385855"},"htmlText":"?&nbsp;","listText":"?&nbsp;","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/164378054","repostId":1103057922,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":168300830,"gmtCreate":1623948538020,"gmtModify":1703824503456,"author":{"id":"3573693462129192","authorId":"3573693462129192","authorIdStr":"3573693462129192","name":"WilliamWCW","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3573693462129192"},"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/168300830","repostId":1103057922,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":161827444,"gmtCreate":1623919066788,"gmtModify":1703823480996,"author":{"id":"3575372039876731","authorId":"3575372039876731","authorIdStr":"3575372039876731","name":"Marco0os","avatar":"https://static.tigerbbs.com/d46598c0c790e4ea6b524daef7d5f0d1","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3575372039876731"},"htmlText":"Time to buy in","listText":"Time to buy in","text":"Time to buy in","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/161827444","repostId":1103057922,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":161826132,"gmtCreate":1623918850626,"gmtModify":1703823474523,"author":{"id":"3569745941427325","authorId":"3569745941427325","authorIdStr":"3569745941427325","name":"Guat65","avatar":"https://static.tigerbbs.com/93d2135fbec26685c7a7aa6e923c9ac3","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3569745941427325"},"htmlText":"Haj","listText":"Haj","text":"Haj","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/161826132","repostId":1103057922,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":4836345,"gmtCreate":1623918936690,"gmtModify":1635313950939,"authorId":3552300010636249,"author":{"id":3552300010636249,"authorId":3552300010636249,"name":"Xav","avatar":"https://static.tigerbbs.com/0a3685fb5cad038c0cc06fad33863aeb","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.11%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":5,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":161826132,"type":1,"supId":0,"prevId":0,"content":"HaJ","text":"HaJ","html":"HaJ"}],"langContent":"EN"},{"id":161820320,"gmtCreate":1623918580960,"gmtModify":1703823467565,"author":{"id":"3581588474178431","authorId":"3581588474178431","authorIdStr":"3581588474178431","name":"PanaCota","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581588474178431"},"htmlText":"Like n comment pls","listText":"Like n comment pls","text":"Like n comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/161820320","repostId":1103057922,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":161887331,"gmtCreate":1623917864323,"gmtModify":1703823451849,"author":{"id":"3581545292648790","authorId":"3581545292648790","authorIdStr":"3581545292648790","name":"Liangwayne","avatar":"https://static.tigerbbs.com/c7725872cc63bfc4a00710c540d2fa75","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3581545292648790"},"htmlText":"What’s with the recent hype on ORPH?","listText":"What’s with the recent hype on ORPH?","text":"What’s with the recent hype on ORPH?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/161887331","repostId":1103057922,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":66,"commentSize":14,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.28.1","shortVersion":"4.28.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1103057922"}